Epilepsy

Epilepsy is the most common, serious, neurological disorder and is characterised by epileptic seizures. It is one of the world’s most prevalent non-communicable diseases; the World Health Organisation estimates that epilepsy affects around 1% of the global population. 1 Danone Research & Innovation has played a pioneering role in the development of a range of medical nutritional solutions for the ketogenic diet, which helps support the nutritional needs of adults and children with difficult to manage (‘refractory’, ‘drug-resistant’) epilepsy.

Discover the latest news and publications in Epilepsy

The ketogenic diet for refractory epilepsy

For patients who don’t respond to anti-epileptic medication, the high fat, low carbohydrate ketogenic diet can be an effective way of reducing seizure frequency.

Learn More

For patients who don’t respond to anti-epileptic medication, the high fat, low carbohydrate ketogenic diet can be an effective way of reducing seizure frequency.

Learn More

Supporting the ketogenic diet

For over 15 years we have been studying the role of nutrition in epilepsy, with the aim of developing high-quality solutions that support the ketogenic diet.

Learn More

For over 15 years we have been studying the role of nutrition in epilepsy, with the aim of developing high-quality solutions that support the ketogenic diet.

Learn More
Our Key Expert
“A heritage of clinical evidence shows the efficacy of dietary management with the ketogenic diet in patients who were not helped by classical medication. More than 50% of these patients, experience over 50% reduction in seizures after starting a ketogenic diet.”

Mirjam Kuhn

Research Program Leader, Inborn Errors of Metabolism and Epilepsy

Danone Research & Innovation

View All People